To determine the impact of the NYS Hepatitis C Testing Law, the NYSDOH drew from multiple data sources that assessed testing levels in New York before and after the law went into effect.
General News
VOCAL-NY and community leaders will attend the meeting to advocate for unrestricted access to Hepatitis C drug coverage.
The purpose of Hep C directory is to provide the public and other providers with a listing of hepatitis C care and treatment providers within New York State.
Your story can change the world. Join us!
The NYS Hep C Coalition has released a 2016 State Budget and Legislative platform.
The NYS attorney general has asked 16 health insurance companies for information on their coverage of Hepatitis C treatments, amid concerns that some companies are restricting coverage of the medications.
The Department of Veterans Affairs will now treat all veterans with Hep C, regardless of stage of liver disease.
FDA Expands Daklinza/Sovaldi Approval to Include Treatment of Hep C Genotype 1
The Health Department today released a new report detailing the city’s hepatitis B and C surveillance, research, and programmatic activities in 2014.
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
